{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "methylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P16455",
      "entity_text" : "MGMT",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "uaz:UA-CLine-5317" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0150" ]
    }
  },
  "verbose_text" : "Meanwhile, it was found that MGMT promoter methylation is a predictive marker for benefit from alkylating agents only in high-grade glioma patients with IDH1 wildtype, but 1p/19q loss in high-grade glioma patients with IDH1 mutant [XREF_BIBR].",
  "reading_complete" : "2020-08-03T17:37:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:34:26Z",
  "trigger" : "methylation",
  "evidence" : [ "MGMT promoter methylation" ],
  "pmc_id" : "5062843",
  "score" : 0
}